1-156136951-C-T
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_170707.4(LMNA):c.1411C>T(p.Arg471Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R471G) has been classified as Pathogenic.
Frequency
Consequence
NM_170707.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.1411C>T | p.Arg471Cys | missense_variant | 8/12 | ENST00000368300.9 | NP_733821.1 | |
LMNA | NM_005572.4 | c.1411C>T | p.Arg471Cys | missense_variant | 8/10 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.1411C>T | p.Arg471Cys | missense_variant | 8/12 | 1 | NM_170707.4 | ENSP00000357283 | P1 | |
LMNA | ENST00000677389.1 | c.1411C>T | p.Arg471Cys | missense_variant | 8/10 | NM_005572.4 | ENSP00000503633 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251152Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135758
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461818Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727208
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1Other:1
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | Nov 23, 2016 | - - |
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 14, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | LMNA: PM2, PM5, PS4:Moderate, PS3:Supporting - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 02, 2023 | Identified in individuals with cardiomyopathy and/or cardiac conduction disease (Al-Saaidi et al., 2018; Mllertz et al., 2018; Rudbeck-Resdal et al., 2019; Hey et al., 2020); Reported in the homozygous state or compound heterozygous state in patients with premature aging syndromes (Cao et al., 2003; Zirn et al., 2008); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Functional studies are inconsistent regarding whether the analyzed properties differ significantly from wild type (Manju et al., 2006; Malashicheva et al., 2013; Malashicheva et al., 2015; Anderson et al., 2021); This variant is associated with the following publications: (PMID: 16772334, 24375749, 24623722, 18348272, 20980393, 24592738, 29943882, 29598884, 10939567, 31383942, 30891417, 30105547, 33019804, 33144682, 12768443, 25982065, 34862408) - |
Mandibuloacral dysplasia with type A lipodystrophy, atypical Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 15, 2008 | - - |
Charcot-Marie-Tooth disease type 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 24, 2023 | Experimental studies have shown that this missense change affects LMNA function (PMID: 16772334, 25982065, 30137533, 30901896). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LMNA protein function. ClinVar contains an entry for this variant (Variation ID: 14503). This variant is also known as c.1623C>T. This missense change has been observed in individual(s) with clinical features of autosomal recessive Hutchinson-Gilford progeria syndrome and/or dilated cardiomyopathy (PMID: 12768443, 18348272, 29943882). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs28928902, gnomAD 0.003%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 471 of the LMNA protein (p.Arg471Cys). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at